Presentation of a case of chest pain leading to coronary artery bypass grafting (CABG) following the third dose of COVID-19 vaccination and an overview of the possible causes of chest pain after COVID-19 vaccination

In the wake of widespread COVID-19 vaccinations, a variety of complications have been reported. Among these, cardiac ischemia stands out as a rare, but significant and potentially dangerous complication, which can progress to myocardial infarction and pose a serious threat to one’s life. Our patient was a 54-year-old man with no risk factors, who developed chest pain five days after the third dose of the COVID-19 vaccine. Notably, he exhibited no symptoms after the first and second doses. For four months, the patient’s symptoms were attributed to inflammatory complications, such as pericarditis and myocarditis, as well as gastrointestinal problems. During this period, he received symptomatic treatment. Due to the persistence of symptoms, heart examinations were conducted, which revealed a constriction at the end of the left main coronary artery. Consequently, the patient underwent coronary artery bypass grafting (CABG). Following cardiac revascularization, the patient’s symptoms were successfully alleviated. Furthermore, his cardiac symptoms were successfully resolved during a six-month follow-up period. The mechanism through which asymptomatic plaques in the coronary vessels are activated following the COVID-19 vaccination or infection remains unclear. Regardless of the cause, any chest discomfort experienced after COVID-19 vaccination or infection should be treated with utmost seriousness, and examinations for acute coronary syndrome should be conducted.

Authors

Institutions

Publication Details

Journal
Journal of Nephropharmacology
Published
2024-12-30
DOI
https://doi.org/10.34172/npj.2025.11664
Primary Topic
Heparin-Induced Thrombocytopenia and Thrombosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Presentation of a case of chest pain leading to coronary artery bypass grafting (CABG) following the third dose of COVID-19 vaccination and an overview of the possible causes of chest pain after COVID-19 vaccination

Roshanak Tirdad, Seyedeh Adeleh Mirjafari, Naser Kachoueian, Manouchehr Hekmat et al.
Journal of Nephropharmacology
Heparin-Induced Thrombocytopenia and Thrombosis
article

Presentation of a case of chest pain leading to coronary artery bypass grafting (CABG) following the third dose of COVID-19 vaccination and an overview of the possible causes of chest pain after COVID-19 vaccination

Roshanak Tirdad, Seyedeh Adeleh Mirjafari, Naser Kachoueian, Manouchehr Hekmat, Mahya Hekmat, Hamid Ghaderi, Zahra Ansari Aval
article en

Abstract

In the wake of widespread COVID-19 vaccinations, a variety of complications have been reported. Among these, cardiac ischemia stands out as a rare, but significant and potentially dangerous complication, which can progress to myocardial infarction and pose a serious threat to one’s life. Our patient was a 54-year-old man with no risk factors, who developed chest pain five days after the third dose of the COVID-19 vaccine. Notably, he exhibited no symptoms after the first and second doses. For four months, the patient’s symptoms were attributed to inflammatory complications, such as pericarditis and myocarditis, as well as gastrointestinal problems. During this period, he received symptomatic treatment. Due to the persistence of symptoms, heart examinations were conducted, which revealed a constriction at the end of the left main coronary artery. Consequently, the patient underwent coronary artery bypass grafting (CABG). Following cardiac revascularization, the patient’s symptoms were successfully alleviated. Furthermore, his cardiac symptoms were successfully resolved during a six-month follow-up period. The mechanism through which asymptomatic plaques in the coronary vessels are activated following the COVID-19 vaccination or infection remains unclear. Regardless of the cause, any chest discomfort experienced after COVID-19 vaccination or infection should be treated with utmost seriousness, and examinations for acute coronary syndrome should be conducted.

Journal of NephropharmacologyVol. 14(1)
Imam Hossein Hospital (IR), Shahid Beheshti University of Medical Sciences (IR)
Good health and well-being
Openalex Percentile: Top 54%
Heparin-Induced Thrombocytopenia and Thrombosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.